Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

Nearly half (45%) of head and neck cancer clinical trials registered from 2005 to 2021 were never published. Trials without statistically significant results and those that were considered incomplete ...

This is where Robot assisted surgery has transformed the landscape of head and neck cancer treatment. Unlike conventional open surgery, which may require large incisions on the face or neck, ...

Master the art of drawing necks with these top tutorials. Proko breaks down neck anatomy, while Jazza covers proportions and structure for beginners. Aaron Blaise dives into the relationship between ...

Head and neck squamous cell carcinomas (HNSCC) are a group of cancers that affect cells in and around our mouth and nose. With 890,000 new cases and 450,000 deaths annually, HNSCC accounts for roughly ...

Advanced disease stage was the strongest predictor of high first-year healthcare costs in Canadian patients with head and neck cancer, a recent analysis found. Patients with stage IV disease had an ...

MSK radiation oncologist Dr. Nancy Lee helped design the clinical trial showing that immunotherapy given around surgery could reduce recurrence of some head and neck cancers. A phase 3 clinical trial ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free survival versus standard care. The U.S. Food and Drug Administration (FDA) ...

Is your screen time wrecking your posture? Maybe you've heard the term "tech neck" by now, but what is it, is it even real, how do you know if you have it, and most importantly, how can it be fixed?

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...